Stock ENZN ENZON PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Enzon Pharmaceuticals, Inc.

Equities

ENZN

US2939041081

Market Closed - OTC Markets
Other stock markets
 19:33:14 13/05/2024 BST 		5-day change 1st Jan Change
0.0849 USD -2.10% Intraday chart for Enzon Pharmaceuticals, Inc. +8.19% -9.26%
05-10 Enzon Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
03-20 Enzon Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
ENZON PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
ENZON PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)
AQ
ENZON PHARMACEUTICALS, INC. : Other Events (form 8-K)
AQ
ENZON PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
ENZON PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
ENZON PHARMACEUTICALS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
ENZON PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
ENZON PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)
AQ
ENZON PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
ENZON PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
Enzon Pharmaceuticals : CONTINENTAL STOCK TRANSFER & TRUST COMPANY (Form 8-K)
PU
ENZON PHARMACEUTICALS, INC. : Entry into a Material Definitive Agreement, Material Modification to Rights of Security Holders, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)
AQ
ENZON PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
ENZON PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)
AQ
Enzon Pharmaceuticals : CEO Andrew Rackear to Retire, Richard L. Feinstein, Enzon's CFO, to Assume Position of CEO and Remain CFO
AQ
ENZON PHARMACEUTICALS, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
AQ
Enzon Pharmaceuticals, Inc. CEO Andrew Rackear to Retire; Richard L. Feinstein, Enzon’s CFO, to Assume Position of CEO and Remain CFO
GL
ENZON PHARMACEUTICALS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
ENZON PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
Enzon Pharmaceuticals : Announces Results of Rights Offering
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ENZN Stock
  4. News Enzon Pharmaceuticals, Inc.
  5. Press Releases